Trinity Biotech plc (TRIB) is a publicly traded Healthcare sector company. As of May 21, 2026, TRIB trades at $0.60 with a market cap of $11.54M and a P/E ratio of 0.00. TRIB moved +6.65% today. Year to date, TRIB is -20.85%; over the trailing twelve months it is -25.11%. Its 52-week range spans $0.48 to $3.44. Rallies surfaces TRIB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the latest TRIB stock research?
Trinity Biotech plc (TRIB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TRIB moved +6.65% today.
ROBERT R MCCORMICK TRIBUNE FOUNDATION sold 17.80K (~$924.52K) on Feb 18, 2004.
ROBERT R MCCORMICK TRIBUNE FOUNDATION sold 92.00K (~$4.82M) on Feb 17, 2004.
ROBERT R MCCORMICK TRIBUNE FOUNDATION sold 65.20K (~$3.39M) on Feb 13, 2004.
TRIB Analyst Consensus
TRIB analyst coverage data. Average price target: $0.00.
Common questions about TRIB
What can I research for TRIB on Rallies?
Trinity Biotech plc (TRIB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TRIB moved +6.65% today.
Does Rallies show live market data for TRIB?
Rallies combines live market context with ticker research for TRIB, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
